What is your opinion on small cap biotech stocks like TSHA and ATAI?


Do the potential benefits outweigh the considerable risk? And if so, how would you determine the size of the risk involved when there aren't many ways to reliably determine if and when these companies become profitable?


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *